Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
StrongMoxi: Moxidectin vs Ivermectin for Strongyloidiasis
NCT04056325Phase 3Completed
- Start
- Nov 2019
- Primary completion
- Apr 2021
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 3 trial of moxidectin in strongyloidiasis. Started Nov 2019; status: completed.
02
Drugs
moxidectin
03
Conditions
strongyloidiasis
Beyond the preview
Go deeper on NCT04056325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04056325.